Clinical Trial Update: A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports that the Reproxalap study in seasonal allergic conjunctivitis completed and results were posted on February 24, 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Seasonal Allergic Conjunctivitis

Drugs mentioned

• Reproxalap (reproxalap)

Snippet

Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Conjunctivitis, Allergic | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-02-24